What is Salus Scientific?
Salus Scientific operates at the intersection of medical ergonomics and radiation safety, providing a comprehensive suite of protective solutions. The company's core portfolio includes high-performance lead vests, the proprietary GLiFT system, and the PeRM platform for real-time radiation monitoring. By focusing on the ambitious goal of Radiation Zero, Salus Scientific addresses the critical need to mitigate occupational exposure risks for physicians and clinical support staff. Their market position is defined by a commitment to reducing physical strain through ergonomic design while simultaneously enhancing the safety standards of modern healthcare environments.
How much funding has Salus Scientific raised?
Salus Scientific has raised a total of $10.2M across 2 funding rounds:
Stock/Share Issuance
$139K
Series A
$10.1M
Stock/Share Issuance (2026): $139K, investors not publicly disclosed
Series A (2026): $10.1M, investors not publicly disclosed
Key Investors in Salus Scientific
Undisclosed Investors
Undisclosed Investors
Undisclosed Investors
What's next for Salus Scientific?
Following this major enterprise-level funding, Salus Scientific is expected to scale its operational capacity and expand the reach of its radiation management services. The capital will likely be deployed to refine the PeRM tracking technology and broaden the distribution of its ergonomic garment line. As the company transitions from its initial development phase into a period of rapid commercial expansion, the focus will remain on establishing new benchmarks for safety in high-risk clinical settings. Strategic growth initiatives will likely prioritize partnerships with major healthcare providers to integrate their protective ecosystem into standard clinical workflows, ensuring long-term sustainability and market leadership.
See full Salus Scientific company page
